- Home
- CVRX vs VNDA Comparison
CVRX vs VNDA Comparison
Compare CVRX & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVRX
- VNDA
- Stock Information
- Founded
- CVRX 2000
- VNDA 2002
- Country
- CVRX United States
- VNDA United States
- Employees
- CVRX N/A
- VNDA N/A
- Industry
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- CVRX Health Care
- VNDA Health Care
- Exchange
- CVRX Nasdaq
- VNDA Nasdaq
- Market Cap
- CVRX 311.3M
- VNDA 270.0M
- IPO Year
- CVRX 2021
- VNDA 2006
- Fundamental
- Price
- CVRX $12.77
- VNDA $4.62
- Analyst Decision
- CVRX Buy
- VNDA Strong Buy
- Analyst Count
- CVRX 7
- VNDA 2
- Target Price
- CVRX $16.67
- VNDA $15.50
- AVG Volume (30 Days)
- CVRX 179.7K
- VNDA 632.8K
- Earning Date
- CVRX 01-23-2025
- VNDA 02-05-2025
- Dividend Yield
- CVRX N/A
- VNDA N/A
- EPS Growth
- CVRX N/A
- VNDA N/A
- EPS
- CVRX N/A
- VNDA N/A
- Revenue
- CVRX $47,255,000.00
- VNDA $190,858,000.00
- Revenue This Year
- CVRX $31.78
- VNDA $5.60
- Revenue Next Year
- CVRX $26.42
- VNDA $42.85
- P/E Ratio
- CVRX N/A
- VNDA N/A
- Revenue Growth
- CVRX 34.38
- VNDA N/A
- 52 Week Low
- CVRX $6.40
- VNDA $3.46
- 52 Week High
- CVRX $33.14
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- CVRX 44.37
- VNDA 45.21
- Support Level
- CVRX $12.57
- VNDA $4.51
- Resistance Level
- CVRX $13.68
- VNDA $4.95
- Average True Range (ATR)
- CVRX 0.74
- VNDA 0.16
- MACD
- CVRX -0.27
- VNDA -0.02
- Stochastic Oscillator
- CVRX 18.35
- VNDA 35.00
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.